Stanley Druckenmiller
ACIU icon

Stanley Druckenmiller’s AC Immune ACIU Stock Holding History

Stanley Druckenmiller’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,324,935
Closed -$6.69M – 63
2019
Q1 		$6.69M Sell
1,324,935
-1,166,582
-47% -$7.42M 0.19% 47
2018
Q4 		$23.5M Hold
2,491,517
– – 1.36% 18
2018
Q3 		$19.9M Buy
2,491,517
+102,817
+4% +$1.03M 0.95% 22
2018
Q2 		$22.3M Hold
2,388,700
– – 1.07% 21
2018
Q1 		$24.7M Hold
2,388,700
– – 1.36% 15
2017
Q4 		$30.6M Hold
2,388,700
– – 1.54% 19
2017
Q3 		$27M Hold
2,388,700
– – 1.23% 21
2017
Q2 		$21M Hold
2,388,700
– – 1.13% 26
2017
Q1 		$24.7M Buy
2,388,700
+809,669
+51% +$9.94M 1.62% 20
2016
Q4 		$20.5M Buy
1,579,031
+79,031
+5% +$1.09M 2% 17
2016
Q3 		$24.7M Buy
+1,500,000
New +$25.9M 2.18% 17

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Stanley Druckenmiller's ACIU Position: Q2 2019 in Review

Stanley Druckenmiller sold out of AC Immune (ACIU) in Q2 2019, closing a stake of 1,324,935 shares — an estimated $6.69M sold.

Stanley Druckenmiller first reported a position in ACIU in Q3 2016 and held it in 11 quarters. The position peaked at $30.6M in Q4 2017. 40 funds tracked by Wall St. Rank hold ACIU as of Q2 2019.

  • Stanley Druckenmiller reported no remaining AC Immune position as of Q2 2019 after selling out during the quarter.
  • Stanley Druckenmiller sold 1,324,935 AC Immune shares in Q2 2019, an estimated $6.69M.
  • Stanley Druckenmiller first reported a position in AC Immune in Q3 2016 and held it in 11 quarters.
  • Stanley Druckenmiller's AC Immune position peaked at $30.6M in Q4 2017.
  • 40 funds tracked by Wall St. Rank held AC Immune as of Q2 2019.

Based on Duquesne Family Office's 13F filing for Q2 2019, filed 14 Aug 2019.